CHARACTERIZATION AND EXPRESSION OF TUBULIN GENES
微管蛋白基因的表征和表达
基本信息
- 批准号:3279094
- 负责人:
- 金额:$ 13.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1982
- 资助国家:美国
- 起止时间:1982-07-01 至 1992-06-30
- 项目状态:已结题
- 来源:
- 关键词:Chlorophyta drug resistance eukaryote flagellum gene expression gene mutation genetic manipulation herbicides immunofluorescence technique laboratory rabbit lethal genes microtubules molecular cloning mutant nucleic acid sequence plant genetics protein biosynthesis regulatory gene transposon /insertion element tubulin
项目摘要
The tubulin gene family in the flagellated unicellular eukaryote,
Chlamydomonas reinhardtii, consists of two beta tubulin genes coding for
identical proteins, and two alpha tubulin genes coding for slightly
different products. Why this haploid organism maintains duplicate genes
for the tubulins, and what rules are played by the genes in the life
cycle, are questions to be addressed. The isolation of mutants resistant
to anti-microtubule herbicides has identified both tubulin and non-
tubulin genes that may be important for microtubule organization and
function. Techniques of molecular biology and genetics will be used to
understand the functions of these genes. Mutant lines resistant to anti-
microtubule drugs will be characterized. Comparison of the distribution,
stability, and assembly properties of microtubules in mutant and wild-
type cells, in the presence and absence of the anti-microtubule drugs,
will be obtained by using immunofluorescence techniques and by examining
flagellar assembly and disassembly. Conditional-lethal mutants will be
examined to determine the cell cycle stage at which they are blocked.
The role of the genes in chromosome transmission will be examined.
Genetic techniques will be used to identify other genes whose products
interact with alpha tubulin in the cell. Isolation of genes identified
by mutational analysis will be accomplished using transformation to
complement Chlamydomonas mutations with cloned Chlamydomonas genes.
Transposon mutagenesis will also be developed as a tool for gene
isolation. Transformation will be used to identify cis-acting sequence
elements important for transcriptional chemotherapeutic agents. The
proposed research will provide insight into the action of anti-tubulin
drugs, as well as the more generally important question of identifying
genes involved in microtubule function in eukaryotic systems.
鞭毛单细胞真核生物中的微管蛋白基因家族,
莱茵衣藻由两个β微管蛋白基因组成,编码
相同的蛋白质和两个阿尔法微管蛋白基因编码
不同的产品。为什么这种单倍体生物体保持重复的基因
对于微管蛋白,以及生命中的基因所起的作用
循环,都是需要解决的问题。抗病突变体的分离
抗微管除草剂已确定微管蛋白和非微管除草剂
微管蛋白基因可能对微管组织和
功能。将使用分子生物学和遗传学技术来
了解这些基因的功能。抗赤霉病突变系
将对微管药物进行表征。比较分布情况,
突变体和野生型微管的稳定性和组装特性
类型细胞,在有无抗微管药物的情况下,
将通过使用免疫荧光技术和通过检查
鞭毛的组装和拆卸。条件致命性突变体将是
检查以确定它们被阻断的细胞周期阶段。
我们将研究这些基因在染色体传递中的作用。
基因技术将被用来识别其他基因的产物
与细胞内的α-微管蛋白相互作用。已鉴定基因的分离
通过突变分析将使用转换到
用克隆的衣藻基因补充衣藻突变。
转座子突变也将作为基因检测的工具而被开发。
与世隔绝。将使用转换来识别顺式作用序列
转录型化疗药物的重要成分。这个
拟议的研究将为了解抗微管蛋白的作用提供洞察
毒品,以及更普遍的重要的识别问题
涉及真核系统中微管功能的基因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CAROLYN D SILFLOW其他文献
CAROLYN D SILFLOW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CAROLYN D SILFLOW', 18)}}的其他基金
CHARACTERIZATION AND EXPRESSION OF TUBULIN GENES
微管蛋白基因的表征和表达
- 批准号:
3279098 - 财政年份:1982
- 资助金额:
$ 13.99万 - 项目类别:
CHARACTERIZATION AND EXPRESSION OF TUBULIN GENES
微管蛋白基因的表征和表达
- 批准号:
3279096 - 财政年份:1982
- 资助金额:
$ 13.99万 - 项目类别:
CHARACTERIZATION AND EXPRESSION OF TUBULIN GENES
微管蛋白基因的表征和表达
- 批准号:
3279095 - 财政年份:1982
- 资助金额:
$ 13.99万 - 项目类别:
CHARACTERIZATION AND EXPRESSION OF TUBULIN GENES
微管蛋白基因的表征和表达
- 批准号:
3279092 - 财政年份:1982
- 资助金额:
$ 13.99万 - 项目类别:
CHARACTERIZATION AND EXPRESSION OF TUBULIN GENES
微管蛋白基因的表征和表达
- 批准号:
3279097 - 财政年份:1982
- 资助金额:
$ 13.99万 - 项目类别:
相似海外基金
Extending the utility and durability of antifungal agents via innovative treatment regimens that minimise drug resistance
通过创新治疗方案最大限度地减少耐药性,延长抗真菌药物的效用和持久性
- 批准号:
MR/Y002164/1 - 财政年份:2024
- 资助金额:
$ 13.99万 - 项目类别:
Research Grant
New approach based on enzyme stimulating of peptides for targeting drug resistance breast cancers
基于肽酶刺激的新方法用于靶向耐药性乳腺癌
- 批准号:
10713648 - 财政年份:2023
- 资助金额:
$ 13.99万 - 项目类别:
Functional and transcriptome analyses of protein kinases in Candida glabrata antifungal drug resistance
光滑念珠菌抗真菌药物耐药性中蛋白激酶的功能和转录组分析
- 批准号:
10643423 - 财政年份:2023
- 资助金额:
$ 13.99万 - 项目类别:
The role and mechanism of RNA m6A modification in the pathogenesis and drug-resistance of prostate cancer
RNA m6A修饰在前列腺癌发病及耐药中的作用及机制
- 批准号:
10638634 - 财政年份:2023
- 资助金额:
$ 13.99万 - 项目类别:
Mechanisms of HIV fitness and drug resistance inferred from high-resolution molecular dynamics and sequence co-variation models
从高分辨率分子动力学和序列共变模型推断出 HIV 适应性和耐药性的机制
- 批准号:
10750627 - 财政年份:2023
- 资助金额:
$ 13.99万 - 项目类别:
Reversing Drug Resistance in Tumors with Clickable Antibody Pairs
利用可点击的抗体对逆转肿瘤的耐药性
- 批准号:
10566266 - 财政年份:2023
- 资助金额:
$ 13.99万 - 项目类别:
Elucidation of prion strain-specific effect of antiprion drugs and drug resistance mechanisms
阐明抗朊病毒药物的朊病毒株特异性作用和耐药机制
- 批准号:
23H02828 - 财政年份:2023
- 资助金额:
$ 13.99万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mathematical Modeling of Drug Resistance Evolution and The Optimal Treatment Strategy in EGFR Mutated Lung Cancer
EGFR突变肺癌耐药演化的数学模型及最佳治疗策略
- 批准号:
22KJ0768 - 财政年份:2023
- 资助金额:
$ 13.99万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Targeting RAGE in tumor and TME to oppose inflammation and drug resistance in obesity associated ER+ breast cancer
靶向肿瘤和 TME 中的 RAGE,对抗肥胖相关 ER 乳腺癌的炎症和耐药性
- 批准号:
10734834 - 财政年份:2023
- 资助金额:
$ 13.99万 - 项目类别:
Targeting chromosomal insatiability for overcoming drug resistance
针对染色体不饱和性克服耐药性
- 批准号:
23K08200 - 财政年份:2023
- 资助金额:
$ 13.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)